Prolia and Gemfibrozil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Prolia (denosumab) and Gemfibrozil (gemfibrozil). Common drug interactions include faeces hard among females and abdominal distension among males.

The phase IV clinical study analyzes what interactions people have when they take Prolia and Gemfibrozil. It is created by eHealthMe based on reports of 42 people who take the same drugs from the FDA, and is updated regularly.

What is Prolia?

Prolia has active ingredients of denosumab. It is often used in osteoporosis. eHealthMe is studying from 151,388 Prolia users. Check the latest studies of Prolia.

What is Gemfibrozil?

Gemfibrozil has active ingredients of gemfibrozil. It is often used in high blood cholesterol. eHealthMe is studying from 18,213 Gemfibrozil users. Check the latest studies of Gemfibrozil.



On Jul, 21, 2026

42 people who take Prolia and Gemfibrozil together, and have interactions are studied.

Prolia and Gemfibrozil drug interactions.

What are the common drug interactions of Prolia and Gemfibrozil, by gender? *:

female:

  1. Faeces hard
  2. Fall
  3. Fatigue (feeling of tiredness)
  4. Full blood count decreased
  5. Fungal infection
  6. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  7. Gastrointestinal oedema (excessive build-up of fluid in the gastrointestinal tract tissues)
  8. Groin pain
  9. Hallucination (an experience involving the perception of something not present)
  10. Hyperparathyroidism (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium)

male:

  1. Abdominal distension
  2. Nausea (feeling of having an urge to vomit)
  3. Cardiac arrest
  4. Chest discomfort
  5. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  6. Compartment syndrome (painful condition that occurs when pressure within the muscles builds to dangerous levels)
  7. Confusional state
  8. Constipation
  9. Cutaneous vasculitis (an inflammatory process affecting the vessel wall that leads to its damage)
  10. Decreased appetite

What are the common drug interactions of Prolia and Gemfibrozil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Oropharyngeal pain
  2. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  3. Pain
  4. Pruritus (severe itching of the skin)
  5. Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue)
  6. Upper respiratory tract infection
  7. Urinary incontinence (inability to control the flow of urine and involuntary urination)
  8. Urticaria (rash of round, red welts on the skin that itch intensely)
  9. Arthralgia (joint pain)
  10. Dehydration (dryness resulting from the removal of water)

60+:

  1. Pain
  2. Arthralgia (joint pain)
  3. Diarrhoea
  4. Eructation (release of gas from the digestive tract)
  5. Erythema (redness of the skin)
  6. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  7. Haemorrhage (bleeding)
  8. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  9. Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood)
  10. Influenza like illness

What are the existing conditions these people have? *

  1. Osteoporosis Post-Menopausal (weak bone with possibility to break after stopped menstrual cycles): 11 people, 26.19%
  2. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 5 people, 11.90%
  3. Vitamin D Decreased: 3 people, 7.14%
  4. Prostate Cancer: 3 people, 7.14%
  5. Multiple Myeloma (cancer of the plasma cells): 3 people, 7.14%
  6. Immunodeficiency Common Variable: 3 people, 7.14%
  7. Blood Phosphorus Increased: 3 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Prolia and Gemfibrozil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Prolia and Gemfibrozil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Prolia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Gemfibrozil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Prolia and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Gemfibrozil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on denosumab and gemfibrozil (the active ingredients of Prolia and Gemfibrozil, respectively), and Prolia and Gemfibrozil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: